Valuation: PharmaEssentia Corporation

Market Cap 49TCr 1.52TCr 1.33TCr 1.23TCr 1.13TCr 2.13TCr 1,46400Cr 2.18TCr 15TCr 5.76TCr 72TCr 5.71TCr 5.58TCr 2,46800Cr P/E 2026 *
45.9x
P/E 2027 * 33.4x
Enterprise Value 47TCr 1.44TCr 1.26TCr 1.16TCr 1.07TCr 2.02TCr 1,38500Cr 2.06TCr 14TCr 5.45TCr 68TCr 5.4TCr 5.28TCr 2,33500Cr EV / Sales 2026 *
18.6x
EV / Sales 2027 * 13.2x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-5.16%
1 week-7.00%
Current month-1.08%
1 month+31.25%
3 months+103.00%
6 months+125.82%
Current year+182.04%
1 week 1,165
Extreme 1165
1,365
1 month 915.01
Extreme 915.0097
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-5.16%-7.00%+168.44%+306.37% 1.52TCr
-7.17%-4.39%+45.51%+79.00% 5.21TCr
+0.24%-1.54%+53.22%+71.85% 5.38TCr
+0.80%-6.31%+3.98%+423.29% 2.35TCr
-0.09%-0.01%-17.62%-14.67% 2.31TCr
-5.95%-2.58%+30.67%-9.58% 1.94TCr
-1.14%+0.03%+31.57%-30.42% 1.76TCr
-6.91%-5.83%+26.53%+636.97% 1.48TCr
+0.43%-1.03%+24.63%+191.40% 1.41TCr
+1.46%+3.13%+58.71%+148.16% 1.28TCr
Average -2.35%-2.05%+42.57%+180.24% 2.46TCr
Weighted average by Cap. -2.58%-2.07%+41.08%+144.32%

Financials

2026 *2027 *
Net sales 2.51TCr 77Cr 68Cr 62Cr 57Cr 108.37Cr 7.45TCr 110.78Cr 745.6Cr 293.26Cr 3.65TCr 290.51Cr 284.13Cr 13TCr 3.46TCr 106.66Cr 93Cr 86Cr 79Cr 149.44Cr 10TCr 152.75Cr 1.03TCr 404.38Cr 5.03TCr 400.58Cr 391.79Cr 17TCr
Net income 1.09TCr 33Cr 29Cr 27Cr 25Cr 47Cr 3.23TCr 48Cr 322.84Cr 126.98Cr 1.58TCr 125.79Cr 123.03Cr 5.44TCr 1.5TCr 46Cr 40Cr 37Cr 34Cr 65Cr 4.45TCr 66Cr 445.3Cr 175.15Cr 2.18TCr 173.5Cr 169.7Cr 7.5TCr
Net Debt -2.65TCr -82Cr -72Cr -66Cr -61Cr -114.67Cr -7.88TCr -117.22Cr -788.91Cr -310.3Cr -3.86TCr -307.38Cr -300.64Cr -13TCr -3.47TCr -107.16Cr -94Cr -86Cr -80Cr -150.14Cr -10TCr -153.47Cr -1.03TCr -406.27Cr -5.05TCr -402.46Cr -393.63Cr -17TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
17/26/17 NT$1,195.00 -5.16% 33,77,763
16/26/16 NT$1,260.00 -4.55% 44,20,281
15/26/15 NT$1,320.00 +10.00% 21,57,754
14/26/14 NT$1,200.00 -4.00% 40,37,292
13/26/13 NT$1,250.00 -2.72% 33,73,173
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,195.00TWD
Average target price
1,073.31TWD
Spread / Average Target
-10.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock